✦ LIBER ✦

Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects

✍ Scribed by Sarah Howles; Ana Guimarães-Walker; Hongbing Yang; Gemma Hancock; Katalin di Gleria; Tony Tarragona-Fiol; Peter Hayes; Jill Gilmour; Anne Bridgeman; Tomáš Hanke; Andrew McMichael; Lucy Dorrell

Book ID: 116963027
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 633 KB
Volume: 28
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2010.08.077

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of recombinant

Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa

✍ Walter Jaoko; Frederick N. Nakwagala; Omu Anzala; Gloria Omosa Manyonyi; Josephi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 397 KB

Enhanced CD8+ T cell immune response aga

Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellular immune responses with the vaccinia virus Western Reserve (WR) vector

✍ Carmen Elena Gómez; Dolores Rodrı́guez; Juan Ramón Rodrı́guez; Fernando Abaitua; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 275 KB